NPI registry status
Active
2026 NPPES data Ophthalmology Physician NPI 1245292176 MD
Verify on CMS → Mark Oberlander, MD
Ophthalmology Physician in Pinellas Park, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,082 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
7K
Medicare Part D claims · 2K beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
59%
generic claims · 41% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
98.9/100
▲ 16 pts above national avg 83.1 · Exceptional
Industry payments
$255.1
7 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Mark Oberlander, MD reported a CMS MIPS final score of 98.9/100 - above the 83.1 national average - and filed 6,923 Medicare Part D claims in 2023.
- 98.9/100
- MIPS score · +16 vs avg
- 7K
- Part D claims, 2023
- 59%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Mark Oberlander, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
99 Top 11% higher than 89% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Oberlander, MD sits
This provider among ophthalmology physician peers
Across the 9,866 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Oberlander, MD writes more Part D claims than 98% of them and scores higher on MIPS quality than 83% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Mark Oberlander, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Mark Oberlander, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Oberlander, MD?
High performer (top quartile)Primary specialty
Ophthalmology Physician
Medicare Part D claims
6,923 388% vs specialty avg
MIPS final score
98.9/100 15.8 pts vs avg
Specialty distribution in Florida
How Ophthalmology Physician compares to other specialties among Florida providers
Medicare quality performance, MIPS
Mark Oberlander, MD's 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 98.9/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) - 98.9/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Mark Oberlander, MD appears in the CMS NPPES registry as an Ophthalmology Physician provider holding MD credentials at 9375 66TH ST N, Pinellas Park, FL, 33782, with a listed phone of (727) 541-4469. NPI 1245292176 was issued on 04/05/2006.
Medicare Part D records for calendar year 2023 show 6,923 prescription claims written by this provider, covering 1,658 Medicare beneficiaries and totaling roughly $897K in drug spend, split 41% brand-name and 59% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 98.9/100 for the 2023 performance year (Quality 100, Cost 100), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,082 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1245292176 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/05/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
98.8891
Final Score
Avg: 83.1
100
Quality
100
Cost
89
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Mark Oberlander, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Southeast Eye Institute PA
Pinellas Park, FL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Oberlander, MD. Source: openpaymentsdata.cms.gov.
Total received
$255
Largest payer
Alcon Vision LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Mark Oberlander, MD. To verify Mark Oberlander, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Mark Oberlander, MD - brand share 41.0%
Ophthalmology Physician average
41% brand-name claims vs 59% generic, on 6,923 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
6,923
Total Claims
$897K
Total Drug Cost
1,658
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 13,013
- Total Day Supply
- 372,701
- Brand vs Generic
- 41% brand / 59% generic
- Brand Drug Cost
- $722K
- Generic Drug Cost
- $175K
- Antibiotic Claims
- 43
Patient Demographics
- Average Patient Age
- 76.7 years
- Avg HCC Risk Score
- 2.06
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 114, 65-74: 537, 75-84: 687, 85+: 320
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mark Oberlander, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
2,181 claims
- Timolol Maleate 605
Timolol Maleate
605 claims
- Lumigan 553
Lumigan
553 claims
- Brimonidine Tartrate 487
Brimonidine Tartrate
487 claims
- Ciprofloxacin Hcl 473
Ciprofloxacin Hcl
473 claims
- Difluprednate 388
Difluprednate
388 claims
- Dorzolamide-Timolol 340
Dorzolamide-Timolol
340 claims
- Prednisolone Acetate 284
Prednisolone Acetate
284 claims
| Drug | Claims |
|---|---|
| Latanoprost | 2,181 |
| Timolol Maleate | 605 |
| Lumigan Bimatoprost | 553 |
| Brimonidine Tartrate | 487 |
| Ciprofloxacin Hcl | 473 |
| Difluprednate | 388 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 340 |
| Prednisolone Acetate | 284 |
| Dorzolamide Hcl | 266 |
| Combigan Brimonidine Tartrate/Timolol | 217 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Mark Oberlander, MD fits within the Ophthalmology Physician landscape nationally.
22,082
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider
Mark Oberlander, MD's 6,923 claims are above the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Oberlander.
Dr. Abbas Abbey
MD
Quincy, FL
Dr. Jody Abrams
M.D.
Sarasota, FL
Dr. Maria Adams
DO
Jacksonville, FL
Dr. Rebecca Adams
MD
Maitland, FL
Dr. Ron Adelman
MD
Jacksonville, FL
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Florida medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Ophthalmology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Florida
Frequently Asked Questions
What is Mark Oberlander, MD's specialty? ▼
Mark Oberlander, MD specializes in Ophthalmology Physician and practices in Pinellas Park, Florida. Credentials: MD.
How much does Mark Oberlander, MD prescribe under Medicare Part D? ▼
In 2023, Mark Oberlander, MD wrote 6,923 Medicare Part D claims totaling $897K in drug costs for 1,658 beneficiaries.
What is Mark Oberlander, MD's Medicare quality score? ▼
Mark Oberlander, MD has a CMS MIPS Final Score of 98.9/100 (Quality: 100, Cost: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mark Oberlander, MD located? ▼
Mark Oberlander, MD is located at 9375 66TH ST N, Pinellas Park, FL, 33782. Phone: (727) 541-4469.
What is Mark Oberlander, MD's NPI number? ▼
Mark Oberlander, MD's National Provider Identifier (NPI) is 1245292176, issued on 04/05/2006.
Does Mark Oberlander, MD prescribe more brand-name or generic drugs? ▼
Mark Oberlander, MD's prescribing is 41% brand-name and 59% generic drugs by claim count, with $722K in brand drug costs.
How many Ophthalmology Physician providers are there in the US? ▼
There are 22,082 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does Mark Oberlander, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Mark Oberlander, MD's most frequently prescribed drugs include Latanoprost, Timolol Maleate, Lumigan. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Oberlander, MD accept Medicare? ▼
Mark Oberlander, MD appears in CMS Medicare data with 6,923 Part D claims and 1,658 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Oberlander, MD's credentials? ▼
Mark Oberlander, MD's NPI is 1245292176 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.